Jul 30, 2025
Viral infections continue to rank among the most significant public health challenges globally, disrupting everyday life, burdening healthcare systems, and contributing to considerable morbidity and mortality. Although many viral infections are self-limiting, others, such as influenza, pediatric viral pneumonia, an...
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
BYSANTI Approval Positions Vanda to Compete in the Antipsychotic Market
Mar 02, 2026
-Agonist.png "Toll-like Receptors Agonist")
Newsletter/Whitepaper